| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152716 Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonane compounds and methods of treatment relating to anti-arrhythmic events |
| 08/05/2004 | US20040152710 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152692 Pyrrolidine sulfonamides |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152668 Vitamin d receptor antagonists and related compositions and methods of use |
| 08/05/2004 | US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152132 Solid phase synthesis of LXR ligands |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152102 for athersclerosis detection/treatment based on gene expression; genetic engineering |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151790 Agent for preventing, improving or treating hypertension |
| 08/05/2004 | US20040151781 Osteoporosis, hormone-related disorders |
| 08/05/2004 | US20040151776 Novel compositions |
| 08/05/2004 | US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/05/2004 | US20040151687 Poly(diallylamine)-based bile acid sequestrants |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/05/2004 | DE10301371A1 Treatment or prophylaxis of cardiovascular, cardiopulmonary or renal diseases, e.g. hypertension combined with hyperlipidemia or atherosclerosis, using combination of telmisartan and atorvastatin |
| 08/05/2004 | CA2518754A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity |
| 08/05/2004 | CA2514100A1 Carboxamide derivatives and the use thereof as factor xa inhibitors |
| 08/05/2004 | CA2513616A1 Composition for oral administration containing capsaicinoids |
| 08/05/2004 | CA2513433A1 Treatment of diseases with alpha-7 nach receptor full agonists |
| 08/05/2004 | CA2513115A1 Amide and ester matrix metalloproteinase inhibitors |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1443106A1 Somatic cell derived embryonic stem cells and its differentiated cells |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442743A1 Medicament comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin converting enzyme (ACE) for use in the treatment of neurodegenerative diseases |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442064A2 Kinases and phosphatases |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442043A1 Condensed pyrimidone derivatives as lp-pla2 inhibitors for the treatment of atherosclerosis |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442040A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 08/04/2004 | EP1442039A1 Pyrimido (4,5-b) indole derivatives |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442021A1 Substituted 1h-quinolin-2-one compounds |
| 08/04/2004 | EP1442020A1 Heterocyclic derivatives of glycinamide and their medical use |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441757A2 Non-neurotoxic plasminogen activating factors for treating stroke |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441731A1 Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441729A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441712A2 Reversing or preventing premature vascular senescence |
| 08/04/2004 | EP1441707A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
| 08/04/2004 | EP1441702A2 Method for treating primary insomnia |
| 08/04/2004 | EP1441698A1 Flashmelt oral dosage formulation |
| 08/04/2004 | EP1441682A1 Method to induce neovascular formation and tissue regeneration |
| 08/04/2004 | EP1441667A1 Improved endoprosthetic device |
| 08/04/2004 | EP1370148A4 Anticholesterolemic edible oil |
| 08/04/2004 | EP1296675B1 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1143968B9 Composition and methods for administration of water-insoluble paclitaxel derivatives |
| 08/04/2004 | EP1140903B1 Aromatic amides |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen |
| 08/04/2004 | EP0873051B1 Modulation of calcium channels |
| 08/04/2004 | CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 08/04/2004 | CN1518557A Novel 5-thio-beta-D-xylopyranoside derivatives, preparation meethod thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518462A Pharmaceutical formulation |
| 08/04/2004 | CN1518454A Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 08/04/2004 | CN1518451A Identifying and treatment of purastic fungi of organism |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1518446A Repinotan kit |
| 08/04/2004 | CN1518443A Stable pharmaceutical composition of pravastatin |
| 08/04/2004 | CN1517365A Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |